Studie: Eli Lillys Mounjaro överglänser Novo Nordisks Wegovy

På fem olika mål för viktminskning, inklusive minskning av midjeomfång, är Eli Lillys Mounjaro överlägsen Novo Nordisks Wegovy, enligt resultatet från en första...

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients

In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.

Tariq Mughal rekryteras till medicinsk chef för Mendus

Tariq Mughal har utsetts till Chief Medical Officer för immunterapibolaget Mendus.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Topp 50: Här är Sveriges högst rankade medicinforskare

Kaj Blennow, Tomas Hökfelt och Anders Björklund toppar listan över de svenska forskare som citeras mest frekvent inom det medicinska forskningsfältet. Se de 50 ...

Join us for a Life Science seminar on april 9th on GoCo

Festo products and solutions are setting the stage for better health through innovative solutions for reliable medical technology and precise, reproducible labo...

Automated dispensing of a viscous hydrogel

A suitable solution developed for UPM Biomedicals In the Festo LifeTech Application Center we tested a setup for UPM Biomedicals for the automatic dispensing of...

Så ska UD främja svensk life science-export

Bredd och innovationskraft gör att svensk life science-export fortsätter att stå stark – men de protektionistiska tendenserna i omvärlden är oroande. Det säger ...

How to avoid measurement inaccuracies due to wear

Expert tip from ZEISS.

Gothenburg-based company acquired by Norwegian diagnostics group

Gentian Diagnostics acquires Gothenburg-based Getica.

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Pharma Outsourcing – Find the right partner

Join the premier metrology and quality assurance event of the year

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

Anna Törner: ”If I fall seriously ill, I’ll move to Finland”

”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.

Elyptas cancertest ska prövas i EU-projekt kring Lynchs syndrom

Det svenska diagnostikbolaget Elypta ska delta i ett stort europeiskt projekt för att möjliggöra tidig upptäckt av cancer hos personer med Lynch syndrom.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

FDA inför AI internt efter lyckat pilottest

Från den 30 juni ska samtliga enheter inom FDA använda AI internt. Det meddelar den amerikanska läkemedelsmyndigheten efter att en första pilotstudie precis avslutats.